Health
PharmAust delivers COVID-19 antiviral breakthrough – Business News
ASX-listed pharmaceutical company, PharmAust continues to kick goals in its endeavours to develop antiviral treatment and prevention therapeutics for COVID-19….
ASX-listed pharmaceutical company, PharmAust continues to kick goals in its endeavours to develop antiviral treatment and prevention therapeutics for COVID-19. The company has once again demonstrated that its lead drug candidates monepantel and monepantel sulfone appear to show protection against cell death in non-human primate systems. Human clinical trials are now on the cards with production of the drug suitable for human consumption having already commenced.
Last year the company revealed monepantel’s…
-
Business21 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors
-
General21 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
General20 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting
-
General23 hours agoPutin says US-Ukraine text could form basis for future peace agreement